ticlopidine has been researched along with B Virus Infection in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernandez, D | 1 |
| Yeo, WM | 1 |
| Brooks, MB | 1 |
| Ness, SL | 1 |
| Divers, TJ | 1 |
| Stokol, T | 1 |
1 trial available for ticlopidine and B Virus Infection
| Article | Year |
|---|---|
Effects of various antiplatelet drugs on ex vivo platelet activation induced by equine herpesvirus type 1.
Topics: Animals; Aspirin; Clopidogrel; Cross-Over Studies; Double-Blind Method; Female; Flow Cytometry; Herp | 2016 |